Sector ratings Regeneron Pharmaceuticals, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-04-15 pm EDT			5-day change	1st Jan Change
753.93 ^USD	-0.21%		-0.83%	-2.32%

Apr. 13	Regeneron Pharmaceuticals, Inc. and Telix Pharmaceuticals Limited Announce Strategic Radiopharma Collaboration	CI
Apr. 13	Regeneron, Telix Enter Radiopharma Collaboration; Telix Shares Up Pre-Bell	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
REGENERON PHARMACEUTICALS, INC.	77.53B		BBB
UCB	60.78B		AA
SAMSUNG BIOLOGICS CO.,LTD.	48.37B		BBB
CSL LIMITED	47.28B		A
BIOGEN INC.	26.26B		AA
MODERNA, INC.	20.96B	-	BBB	-		-
INCYTE CORPORATION	19.44B		AA
SWEDISH ORPHAN BIOVITRUM AB	15.48B		AA
BRIDGEBIO PHARMA, INC.	15.11B	-	BB	-		-
ALTEOGEN INC.	12.85B		CCC
BIOMARIN PHARMACEUTICAL INC.	10.67B		BBB			-
AXSOME THERAPEUTICS, INC.	9.42B		BBB			-
KRYSTAL BIOTECH, INC.	7.95B	-	B	-		-
SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD	7.8B	-	-	-		-	-
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	7.25B	-	BB	-		-	-
GRIFOLS, S.A.	6.91B		BB
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.	6.03B	-	-	-	-	-	-	-
GAN & LEE PHARMACEUTICALS.	5.61B		-			-
SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.	5.44B		A			-	-
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	5.58B		A
Average	20.84B		A
Weighted average by Cap.			A